bioRxiv ScienceSearch

Biology subjects

Jacco Wallinga

Publications and source records attributed to Jacco Wallinga.

2 recordsLinked to original sources

New method to reconstruct phylogenetic and transmission trees with sequence data from infectious disease outbreaks

Whole-genome sequencing (WGS) of pathogens from host samples becomes more and more routine during infectious disease outbreaks. These data provide information on possible transmission events which can be used for further epidemiologic analyses, such as identification of risk factors for infectivity and transmission. However, the relationship between transmission events and WGS data is obscured by uncertainty arising from four largely unobserved processes: transmission, case observation, within-host pathogen dynamics and mutation. To properly resolve transmission events, these processes need to be taken into account. Recent years have seen much progress in theory and method development, but applications are tailored to specific datasets with matching model assumptions and code, or otherwise make simplifying assumptions that break up the dependency between the four processes. To obtain a method with wider applicability, we have developed a novel approach to reconstruct transmission trees with WGS data. Our approach combines elementary models for transmission, case observation, within-host pathogen dynamics, and mutation. We use Bayesian inference with MCMC for which we have designed novel proposal steps to efficiently traverse the posterior distribution, taking account of all unobserved processes at once. This allows for efficient sampling of transmission trees from the posterior distribution, and robust estimation of consensus transmission trees. We implemented the proposed method in a new R package phybreak. The method performs well in tests of both new and published simulated data. We apply the model to to five datasets on densely sampled infectious disease outbreaks, covering a wide range of epidemiological settings. Using only sampling times and sequences as data, our analyses confirmed the original results or improved on them: the more realistic infection times place more confidence in the inferred transmission trees.\n\nAuthor SummaryIt is becoming easier and cheaper to obtain whole genome sequences of pathogen samples during outbreaks of infectious diseases. If all hosts during an outbreak are sampled, and these samples are sequenced, the small differences between the sequences (single nucleotide polymorphisms, SNPs) give information on the transmission tree, i.e. who infected whom, and when. However, correctly inferring this tree is not straightforward, because SNPs arise from unobserved processes including infection events, as well as pathogen growth and mutation within the hosts. Several methods have been developed in recent years, but none so generic and easily accessible that it can easily be applied to new settings and datasets. We have developed a new model and method to infer transmission trees without putting prior limiting constraints on the order of unobserved events. The method is easily accessible in an R package implementation. We show that the method performs well on new and previously published simulated data. We illustrate applicability to a wide range of infectious diseases and settings by analysing five published datasets on densely sampled infectious disease outbreaks, confirming or improving the original results.

Epidemiology

Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a multi-strain A/H3N2 vaccine component

Some past epidemics of different influenza (sub)types (particularly A/H3N2) in the US saw co-circulation of vaccine-type and variant strains. There is evidence that natural infection with one influenza (sub)type offers short-term protection against infection with another influenza (sub)type (henceforth, cross-immunity). This suggests that such cross-immunity for strains within a (sub)type is expected to be strong. Therefore, while vaccination effective against one strain may reduce transmission of that strain, this may also lead to a reduction of the ability of the vaccine-type strain to suppress spread of a variant strain. It remains unclear what the joint effect of vaccination and cross-immunity is for co-circulating influenza strains, and what is the potential benefit of a bivalent vaccine that protects against both strains.\n\nWe simulated co-circulation of vaccine-type and variant strains under a variety of scenarios. In each scenario, we considered the case when the vaccine efficacy against the variant strain is lower than the efficacy against the vaccine-type strain (monovalent vaccine), as well the case when vaccine is equally efficacious against both strains (bivalent vaccine).\n\nAdministration of a bivalent vaccine results in a significant reduction in the overall incidence of infection compared to administration of a monovalent vaccine, even with lower coverage by the bivalent vaccine. Additionally, we found that the stronger is the degree of cross-immunity, the less beneficial is the increase in coverage levels for the monovalent vaccine, and the more beneficial is the introduction of the bivalent vaccine.\n\nOur work exhibits the limitations of influenza vaccines that have low efficacy against non-vaccine strains, and demonstrates the benefits of vaccines that offer good protection against multiple influenza strains. The results elucidate the need for guarding against the potential co-circulation of non-vaccine strains for an influenza (sub)type, at least during select seasons, possibly through inclusion of multiple strains within a (sub)type (particularly A/H3N2) in a vaccine.

Epidemiology